Correction of factor VIII deficiency in hemophilia A mice that target expression of a single chain variant of human factor VIII to epidermis.

被引：0
|
作者：
Kobayashi, S
Sarkar, R
Kazazian, HH
Fakharzadeh, SS
机构：
[1] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA
来源：
AMERICAN JOURNAL OF HUMAN GENETICS | 2000年 / 67卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
2421
引用
收藏
页码：429 / 429
页数：1
相关论文
共 50 条
  • [41] Dual vectors expressing murine factor VIII result in sustained correction of hemophilia A mice
    Mah, C
    Sarkar, R
    Zolotukhin, I
    Schleissing, M
    Xiao, X
    Kazazian, HH
    Byrne, BJ
    HUMAN GENE THERAPY, 2003, 14 (02) : 143 - 152
  • [42] Immune Tolerance to Human Factor VIII Induced by Liver-Specific Expression of a Human Factor VIII Transgene in Hemophilic Mice
    van Helden, Pauline
    Sasgary, Maria
    Unterthurner, Sabine
    Schuster, Maria
    Antoine, Gerhard
    Zimmermann, Klaus
    Ahmad, Ralfi Uddin
    Muchitsch, Eva M.
    Ehrlich, Hartmut J.
    Schwarz, Hans Peter
    Reipert, Birgit M.
    BLOOD, 2008, 112 (11) : 1162 - 1162
  • [43] Enhanced Factor VIII Heavy Chain for Gene Therapy of Hemophilia A
    Chen, Lingxia
    Lu, Hui
    Wang, Jinhui
    Sarkar, Rita
    Yang, Xiao
    Wang, Hongli
    High, Katherine A.
    Xiao, Weidong
    MOLECULAR THERAPY, 2009, 17 (03) : 417 - 424
  • [44] Sustained expression of therapeutic levels of human factor VIII in mice
    Connelly, S
    Gardner, JM
    Lyons, RM
    McClelland, A
    Kaleko, M
    BLOOD, 1996, 87 (11) : 4671 - 4677
  • [45] Sustained human factor VIII expression in hemophilia a mice following systemic delivery of a gutless adenoviral vector
    Reddy, PS
    Sakhuja, K
    Ganesh, S
    Yang, LJ
    Kayda, D
    Brann, T
    Pattison, S
    Golightly, D
    Idamakanti, N
    Pinkstaff, A
    Kaloss, M
    Barjot, C
    Chamberlain, JS
    Kaleko, M
    Connelly, S
    MOLECULAR THERAPY, 2002, 5 (01) : 63 - 73
  • [46] A Novel Factor VIII Variant with Enhanced Secretion for Gene Therapy of Hemophilia A
    Cao, Wenjing
    Dong, Biao
    Firrman, Jenni A.
    Moore, Andrea R.
    Wang, Qizhao
    Roberts, Sean A.
    Xiao, Weidong
    MOLECULAR THERAPY, 2014, 22 : S176 - S176
  • [47] Efficacy of a PEGylated variant of recombinant factor VIII in mouse models of hemophilia A
    Hoellriegl, W.
    Schiviz, A.
    Eder, B.
    Verdino, D.
    Scheif-Linger, F.
    Schwarz, H.
    Muchitsch, E.
    HAEMOPHILIA, 2012, 18 : 37 - 37
  • [48] Variant of intron 22 inversions in the factor VIII gene in severe hemophilia A
    Yamazaki, E
    Mohri, H
    Inaba, H
    Harano, H
    Kanamori, H
    Okubo, T
    BLOOD COAGULATION & FIBRINOLYSIS, 1997, 8 (07) : 445 - 449
  • [49] Factor VIII associated with lipidic nanoparticles retains efficacy in the presence of anti-factor VIII antibodies in hemophilia A mice
    Shetty, Krithika A.
    Kosloski, Matthew P.
    Mager, Donald E.
    Balu-Iyer, Sathy V.
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2016, 37 (07) : 409 - 420
  • [50] HEMOPHILIA-A (FACTOR-VIII DEFICIENCY) IN GERMAN SHEPHERD DOGS
    LITTLEWOOD, JD
    JOURNAL OF SMALL ANIMAL PRACTICE, 1988, 29 (02) : 117 - 128
12345